| Tag | Content |
|---|
EnhancerAtlas ID | HS105-54613 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr3:16443140-16444910 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL2 | MA0478.1 | chr3:16443676-16443687 | CTGAGTCACCC | - | 6.02 | | HSF1 | MA0486.2 | chr3:16443544-16443557 | TTCTGGAATGTTC | + | 6.59 | | IRF1 | MA0050.2 | chr3:16443742-16443763 | TTCCTCTTTCTCTTTCAATGT | + | 6.19 | | JUNB | MA0490.1 | chr3:16443676-16443687 | CTGAGTCACCC | - | 6.02 | | NFE2L1 | MA0089.2 | chr3:16444137-16444152 | AATGATGAGTCATTT | - | 6.18 | | RREB1 | MA0073.1 | chr3:16443923-16443943 | CCCCTCAACAACCCCCCTCC | + | 6.14 | | RREB1 | MA0073.1 | chr3:16443978-16443998 | GGTTTGTGGGTGGGTTCTGG | - | 6.26 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_00074 | chr3:16439573-16445088 | Adipose_Nuclei | | SE_58304 | chr3:16407941-16571531 | Ly1 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I016402 | chr3 | 16444095 | 16444292 |
|
Enhancer Sequence | TCTGGATTTT ACCAAAGTAT ATCTCTGTTA TGAATTGGCA AAAAACTGGT CCTTCACCAC 60
AGATAGCGTG AGACAAACTG GTCTAGATCT TGCAGTCTTT TTAATAGATC TGTCTGCTTA 120
CGCTGAAAAA CCAAGAAACC TCACAAGAAA ATATAAACTT AACTTCTCTA AAACAAAGCC 180
AGCCAGGTGC CCAACCAAAC AACAGATCTT GCAATTTTGG GTCCATATTT CCACCAGGCA 240
TCAGAGAGCG GAGGCTCAGT GGAAACTGCC CCTTGAGATG GGCATGTGCC ACTGGATGAC 300
CATCCTTACC ACCATTCTTG CCTGCTCTCA GGGTTGACAC CTCAGACACC CACATCTCTG 360
TTCCTGGCTT TCTTGCAAGT CCCAGCCCAA CAACCACAGC TGCCTTCTGG AATGTTCCCT 420
GAGTGTCCCC CTGACCCCTC AAGTCTTCAT ACAACCATCC CCATTCTCAT CACCTCTCTG 480
CCCCCAGGGC TCCTCATGCT GTGTTCTTGG TCCTTACAGA TGACCCCATC TCACACCTGA 540
GTCACCCAGG TGTCATCCTT GGCACCTCTC TCTCCTTCAA TGACACGAAG GTTTAGTGAG 600
TATTCCTCTT TCTCTTTCAA TGTATCCATT AACTCGACGC TTATGTATTA AGTCCTGAAG 660
ACACAACAGT AAGCAGGGTA CCCCATTGCC CCCTGCAAGG CCTGCGCCAG CCGCCAGCTC 720
ACTGTCTTCC ACTCTGAAGA CACACTCATT GCTGGGATGA CACTCCATTT TCTGCCTTTA 780
CTTCCCCTCA ACAACCCCCC TCCCCAGGTT CATCTTTTTT AAATGTCACT ATTCTCTTGG 840
TTTGTGGGTG GGTTCTGGTG CAGCAAGCAC AGGAGAGCCT TTTTAACATA ATTTTCATTT 900
CACTCTGAAT TGGCATCTTA CCCTAATTAA AATTAGACTC TCTGCACCGC ACTTGTAGAA 960
ATGAAACTCT GAATACTCAA CAATCAGCCA GAAAGTAAAT GATGAGTCAT TTACATAACA 1020
GGCAAAATTT CATCATCCCG GAGATTTGGG ATATTCTGTT TCATTAAAAG AAGCCATTGA 1080
GATTTTTCCA TCTGTCAAGG TGCTTTCTTT AGGTTGAGGC ATAAGTAGCA TCATTCGGTT 1140
TTCTGAAGGA CAATGTACTC GGTTTAATCC AGGACAGTAC ACTCATTGAG TGGGACCAGC 1200
CGCCCCTCAA CGGTCTTCAT TGCAAAGGCT CAGTGGGCCA GTGCAAGATG AACCTAGTTC 1260
TTAAGGAGAT CAGGGAGGTC AGGAGCTCCA TCACAAAAGG GAGTCAACTT GGGGAACAGA 1320
GCCCAGAGCT GAGGGCCTGA AGGCAAAGGC CACCATGTCT TATCTGGACA AGGGCAGGGA 1380
GCGTGGCTTT CTCCCGCAGG CAGGACGAGG CAATTTCCAT CAGCAGAACC TGGGCGGCAA 1440
GGGCCTGGAG CCCATCCTTC ACTGAGGGGA CACCTTCAAG GCACTCCAAC ATCTGACCCC 1500
ATGTACCCAA CACGCGTTAT GGCCATTTGC CTCCTATGCT CAACCTCACA TTCTGGCTCT 1560
GACAGCCTCC ACCTCTGTCC AGAAAGGGAC AAGCTATACA GGAGAGGTAG CATGGCCAAG 1620
TGCTCTAGAA CACAGTCCCT GGGTCCAACA GGCTGGGTTC ATATCTCAGT CCTGCCATGC 1680
ACAGTTATAA CATTGGCAAA CTGCATAGCT TCTCTGTGTC TCAGTTTCTT CATCTGTCAA 1740
ATGAGGATAA GTCTTCACAG GCATGAGATG 1770
|
